11.12.2024 • News

Statement: Rolf Kuropka, CEO, Krahn Chemie Group

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

I believe that challenges and opportunities are two sides of the same coin. It is up to us to turn it to the favorable side. Good examples are the overwhelming European legislation, where we can act as a consultant and facilitator for our customers, and restrictions regarding the use of raw materials, where we could lead the way in finding sustainable alternatives.

I’m fully convinced that every investment which helps to make our planet a better place for future generations is worthwhile. As a distributor, we can play a crucial role in driving sustainability: acting as a consultant for our typically smaller customers, inspiring our suppliers, and serving as an “detective” discovering interesting new sources. Absolutely, through a perfect cooperative approach with our suppliers and customers: this can involve finding innovative raw material sources from our customers’ waste streams, unleashing synergies from the combination of raw materials from our various suppliers in our application laboratories and developing unique testing procedures to support our suppliers and customers in their product development.

Rolf Kuropka, Krahn Chemie Group © Krahn Chemie
Rolf Kuropka, Krahn Chemie Group © Krahn Chemie

“As a distributor, we can play a crucial role in driving sustainability: acting as a consultant for our typically smaller customers and inspiring our suppliers”

Company

Krahn Chemie

Mühlenhagen 35
20539 Hamburg
Germany

Company contact







Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read